The Janssen Pharmaceutical Companies of Johnson & Johnson address some of the most devastating and complex diseases of our age through research and development of prescription medicines including biologics and other novel treatments. Spending more than $6 billion in R&D in 2014, Janssen is investing in a transformative future, changing the way diseases are interpreted, managed and prevented. Our pharmaceutical and biologic medicines are focused in five areas of healthcare. Click on the therapeutic area below to find medicines.
Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with key stakeholders such as academic researchers, governments, patient groups, healthcare professionals and more. This approach ensures we can discover, develop and deliver the kinds of innovative pharmaceutical medicines that address some of the most serious needs of our time. Learn more about Janssen at Janssen.com.